Aging is progressive physiological degeneration and consequently declined function, which is linked to senescence on both cellular and organ levels. Accumulating studies indicate that long noncoding RNAs (lncRNAs) play important roles in cellular senescence at all levels-transcriptional, post-transcriptional, translational, and post-translational. Understanding the molecular mechanism of lncRNAs underlying senescence could facilitate interpretation and intervention of aging and age-related diseases. In this review, we describe categories of known and novel lncRNAs that have been involved in the progression of senescence. We also identify the lncRNAs implicated in diseases arising from age-driven degeneration or dysfunction in some representative organs and systems (brains, liver, muscle, cardiovascular system, bone pancreatic islets, and immune system). Improved comprehension of lncRNAs in the aging process on all levels, from cell to organismal, may provide new insights into the amelioration of age-related pathologies and prolonged healthspan.
ity and telomere attrition, advances in aging research exhibit a lot more determinants of aging, rendering this physiological process complex and complicated. Senescence on both cellular and organ levels gradually causes age-related diseases, such as cardiovascular diseases, Alzheimer's disease (AD), cancer, and sarcopenia, most in forms of comorbidities. Meanwhile, consequent fragility and frailty result in high mortality. As world population above 60 is expected to double and reach 22% by 2050, the increases in morbidity and mortality are noted in elderly populations. 2, 3 Therefore, the boosting aging global population becomes a critical healthcare issue, which demands further exploration through explicit mechanisms underlying the aging process. [4] [5] [6] Age-related changes in the cellular proteome and transcriptome levels are indispensable in physiological alterations in cells, tissues, and organ systems during aging. Recent advancement in microarrays and sequencing techniques has lead to a better understanding of various important mammalian genomes (eg, human, rat, and mouse) and their respective cellular, tissue, and organ-specific transcriptomes. Series of multitude projects, including Functional Annotation of the Mammalian Genome and Encyclopedia of DNA elements, have revealed that only about 2% of transcripts are protein-coding RNAs, and the reminders are pervasively transcribed into myriad multifunctional forms of RNA molecules known as noncoding RNAs (ncRNAs). 7, 8 Based on the transcript length, these ncRNAs are divided into small (20-30 nt) ncRNAs and long (>200 nt) ncRNAs (lncRNAs). 8 lncRNAs are poorly conserved but abundant heterogeneous regulatory ncRNAs. Based on their genomic location, orientation, and mode of transcription, they are further classified into sense, antisense, bidirectional, promoter-associated, enhancer-associated, pseudogene-associated,
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telomere-associated, and circular lncRNAs in a broad but mutually nonexclusive manner. 9, 10 They act as regulatory players with versatile roles in different modes. lncRNAs regulate gene expression virtually at all levels-transcriptional, RNA processing, translational, and post-translational-by interacting with DNA, RNA, or proteins 11 ( Figure 1 ). The subcellular localization of lncRNAs may also bring additional complexity to their function. 12 lncRNAs are increasingly recognized as essential in various cellular processes such as proliferation, apoptosis, differentiation, and senescence for the impact on gene expression. [13] [14] [15] [16] [17] [18] lncRNAs also underly important pathologic processes in age-mediated function, including metabolic imbalances, neurodegeneration, and cancer. 19, 20 In this review, the emphasis is given to the association of lncRNAs with the aging process in cellular and organic levels with the forms of age-related frequently occurring diseases.
| lncRNAs IN CELLULAR AGING
Senescence is characterized as a stable form of growth arrest in untransformed cells, triggered by telomere attrition, chromosome destabilization, DNA damage, mitochondrial dysfunction, oncogene activation, and other cellular stress linked to cell cycle. 21 Senescent cells are featured in morphological, secretory, and molecular aspects.
F I G U R E 1 Cellular functions of long noncoding RNAs (lncRNAs). Genomic location relative to regulatory mechanisms of lncRNAs in the nucleus, cytoplasm, and extracellular compartments. Nuclear-localized lncRNAs can act as (A) enhancers to induce transcription in cis or in trans; or (B) decoy to induce transcription factors and chromatin modifiers, blocking their binding to DNA; or (C) molecular signals to activate or silence gene expression through signaling to regulatory pathways; or (D) guide to instruct transcriptional elements (eg, chromatin modifiers) to specific target sites; or (E) scaffolds, binding proteins complexes to affect gene expression, and (F) then can modulate alternative splicing of pre-mRNAs. In the cytoplasm, lncRNAs can serve as (G) microRNAs (miRNAs) sponge to block their effect and then can control (H) translational events, or (I) protein-protein interaction, or (J) protein phosphorylation and activation of signaling pathways. K, They can regulate the maturation of ribosomal RNAs. Finally, some lncRNAs can be (L) released in the form of exosomes and transferred to other cells to (M) function as precursors of miRNAs and other regulatory small RNA HE ET AL.
| 159
Distinctive features include flattened, enlarged cell size, increased SA-β-galactosidase activity, production of senescence-associated secretory phenotype (SASP), and differential expression of senes- 88 Consistently, depletion of PANDA by siRNA results in exit from senescence in senescent fibroblasts. 88 The flexibility in switching between proliferation and senescence enables PANDA as a potential target for senescence and age-related intervention.
| lincRNA-p21
P53-mediated lincRNA-p21 is firstly identified as a regulator of p21 by recruiting hnRNP-K to the promoter region of p21, thus diminishing cell proliferation in mouse embryonic fibroblasts. 89 
| Telomere-associated lncRNAs
Telomeres are the protective nucleoprotein caps at the end of chromosomes, which shorten with every cell division. Preservation of the telomere lengths requires telomerase reverse transcriptase combined with telomere RNA component (TERC). 111 Telomere attrition is characterized as a key hallmark in cellular senescence and organismal aging. 1, 22 lncRNAs play roles in the organization of telomere dynamics, indicating a possible correlation with telomere-associated diseases.
| TERC
TERC functions as a template for telomeric DNA synthesis by telomerase. Its involvement in senescence and aging is probably due to gradual loss of telomerase activity. TERC-deficient mice displayed pulmonary premature aging and osteoporosis. 112, 113 The pulmonary senescence-associated inflammatory phenotype could partly be explained by telomerase-mediated NF-κB transcription. 114 Introduction of TERC in telomerase-deficient mice was confirmed to rescue premature aging phenotypes by restoring functional telomerase. 115 Apart from that, TERC could affect angiogenesis and metastasis-related genes' expression without affecting telomere length. 128 The mystery of TERRA in senescence is expecting to be unveiled.
| Chromatin-modulating lncRNAs
Chromatin remodeling occurs within senescence and aging process.
Alterations in chromatin features include epigenetic changes, heterochromatinization, histone modification, and DNA methylation.
lncRNAs usually serve as modifiers, decoys, or guides, by recruiting various histone and DNA methyltransferase to the site of chromosome inactivation (eg, Xist, HOTAIR, and lncRNA-p21) or by directing transcriptional factors to bind with regulatory DNA elements (eg, AIR). Several representative lncRNAs are mentioned in the previous parts, such as H19, ANRIL, and TERRA. In this part, we will focus on those unmentioned related lncRNAs.
| Xist
Transcribed from the inactive X chromosome, Xist is responsible for gene imprinting and X chromosome inactivation in females by blocking the access of RNA polymerase II. 129, 130 Level of Xist declines in senescent cells, 131 yet its function in senescence is unclear.
| Kcnq1ot1
KCNQ1-overlapping transcript 1 (Kcnq1ot1) is a paternally expressed antisense lncRNA to Kcnq1ot1 gene. 132 It exerts an impact on nearby imprinted genes, including CDKN1C and KCNQ1, by recruiting chromatin remodeling complexes to the paternal DMR-LIT1 locus. 133, 134 As the role of CDKN1C in cell cycle progression, Kcnq1ot1 affects cellular senescence and aging process. Moreover, the suppressed level of Kcnq1ot1 is relevant to age-related diseases, such as type 2 diabetes, atherosclerosis, myocardial infarction, and various cancers. 151 Similarly, pRNA serves to silence repeated nucleolar ribosomal RNA (rRNA) through the formation of DNA-RNA triplex and subsequent repressive DNA methylation at the rRNA promoter. 152 As levels of rRNA are tightly correlated with senescence, aging process and age-related neurodegenerative diseases (eg, AD and Werner syndrome), and symptoms (eg, depression), [153] [154] [155] the implication of pRNA in this field remains to be confirmed. PTENpg1 negatively regulates PTEN level, the latter of which is known suppressor of senescence, aging, and tumor.
| SASP-associated lncRNAs
SASP is a critical trait of senescent cells. Also, the accumulation of senescent cells during aging provokes production of SASP factors, facilitating low-grade chronic inflammation and age-related diseases.
Regulation of lncRNAs contributes to innate immune responses, such as macrophage polarization and inflammatory factor secretion.
| 17A
17A controls the alternate spicing of GABA receptor and subsequent downstream signaling. 156, 157 It was reported to be triggered by inflammation in AD brains, leading to increase in Aβ accumulation. 
| ASncmtRNA-2
Mitochondria play a significant role in the onset of senescence, as accumulated mitochondrial-derived ROS induces senescence by adaptive modulation on the transcription of nuclear-encoded factors. 182 Antisense noncoding mitochondrial RNA-2 (ASncmtRNA-2) is exported from mitochondria to nucleus, whose flow direction is consistent with the mitochondria retrograde signaling. This lncRNA is involved in replicative senescence in ECs by maintaining the cell cycle arrest in G2/M phase through the production of has-miR-4485
and has-miR-1973. Meanwhile, p16 displayed similar ASncmtRNA-2 pattern in the senescent cells, suggesting a possible coregulation of the two genes. 183 Expression of ASncmtRNA-2 was preponderant in aged murine aortas, 183 indicating its impact on vascular aging.
| SPECIFIC EXPRESSION Of lncRNAs IN DIFFEREN T TISSUES/ ORGANS DURING AGING
Changes in morphology and physiology determine specific agerelated diseases in different tissues and organs. We firstly summarized the various changes and characterized diseases found in the elderly. Then, we reviewed the reported specific expressed lncRNAs according to the localization or diseases (Table 1) . and amyloid plaques in AD brain. 189 Expression of BC200 was decreased in the normal aging brain, but elevated in AD brain. 190 The accumulated pathological protein in PD brain is α-synuclein, contained in Lewy body. The identified genes involved in PD pathology include Parkin, PINK1, PARK-7, and LRRK2. Therefore, further investigations regarding lncRNAs targeting these genes or linked to the pathogenesis of α-synuclein would be a promising strategy in PD therapy. 103, 188, 191, 192 
| Brain

| Liver
Liver blood flow is estimated to be reduced by 20%-40%, which seems to be consistent with the shrinkage of liver volume. 193, 194 Accumulated lipofuscin in hepatocytes contributes to chronic oxidative stress, and vacuolation of hepatocyte nuclei is linked to diabetes and nonalcoholic fatty liver diseases (NAFLD), both of which are possible markers of hepatocyte senescence. 195, 196 Age-related decline in drug metabolism and regeneration capacity, and abnormal immune responses enhance vulnerability to acute liver injury, liver fibrosis, hepatitis C, NAFLD, alcoholic liver diseases, and liver tumor.
Alterations in C/EBP family and telomere reverse transcriptase by repressive chromatin remodeling are observed in aged drug-induced liver injury, resulting in impaired regenerative capacity and fibrosis. 197 A group of differentially expressed lncRNAs in mouse have been identified in the above pathophysiologies, including NEAT1, MEG3, Rian, and Mirg. 198 Rian and MEG3 could regulate proliferation by directly recruiting PRC2. 199 Mirg could predict certain cell cycle factors, such as Myc and p53. 200 Moreover, the involvement of ANRASSF1, ecCEBPA, and some other lncRNAs, whose target genes are involved in liver metabolism, cell cycle, or local inflammatory responses, remains to be elucidated.
| Muscle
Muscle mass declines progressively during aging. Sarcopenia is a common age-related skeletal muscle degeneration, characterized by reduced muscle mass and muscle fibers. The underlying mechanisms are multifaceted, including a sedentary lifestyle, reduced hormonal level, and increased inflammation, loss of proteostasis, and mitochondrial dysfunction. 201 H19 is implicated in skeletal muscle differentiation by acting as a molecular sponge to bind the miRlet-7. 60 H19 is highly expressed in skeletal muscle, as well as H19-encoded miRNAs, miRlet-7, and miRlet-7 during muscle regeneration, all of which are regulated by SMAD1/5. 67 The muscle-specific lncMD1 exerts as a decoy for miR-133 and miR-135, which is enhanced by HuR, to limit its impact on the expression of Elavl1 in muscle differentiation during muscle aging. HuR plays a direct role in muscle wasting and sarcopenia. 202, 203 Stimulated by myostatin, MALAT1 regulates muscle cell proliferation and differentiation, thus influencing muscle aging. 204, 205 SIRT1-AS was recently reported to play a role in myogenesis, as its antisense target SIRT1 could prevent senescence and aging through myogenic program. 206, 207 There are other lncRNAs involved in myogenesis, such as YY1, Glt2/Meg3, and MAR1, whose function in muscle aging needs further exploration. is upregulated during vascular aging. Silencing MEG3 could prevent aging-mediated inhibition of sprouting activity and EC proliferation. 217, 218 ANRIL is known as an independent risk factor for CAD.
However, functional annotation of this lncRNA in atherosclerosis is controversial, as different splicing variants of ANRIL might play distinct roles. [219] [220] [221] [222] [223] 
| Pancreatic islets
Type 2 diabetes mellitus (T2DM) is considered as an age-related disease, as it is well documented that aging is associated with declined insulin action and β-cell secretory activity. 249 Moreover, pancreatic islet cell senescence partly contributes to the rise of T2DM in the elderly. 250 Growing evidence implicates lncRNAs in the etiology of 
| CON CLUSION AND PERSPECTIVE S
As concluding remarks, the emerging role of lncRNAs as regulators of cellular senescence and age-related diseases is still in its infancy.
Numerous diseases arise with advancing age, yet we just pick a couple of them to discuss in our review. Cancer is another kind of age- 
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